Pregnancy: The safety of Meropenem (Merozan) in human pregnancy has not been established. Animal studies have not shown any adverse effect on the developing foetus. Meropenem (Merozan) should not be used in pregnancy unless the potential benefit justifies the potential risk to the foetus. In every case, it should be used under the direct supervision of a physician.
Lactation: Meropenem is detectable at very low concentrations in animal breast milk. Meropenem (Merozan) should not be used in breast-feeding women unless the potential benefit justifies the potential risk to the baby.